| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 207.15B | 169.60B | 152.41B | 125.93B | 110.05B |
| Gross Profit | 116.87B | 98.76B | 84.66B | 73.82B | 63.01B |
| EBITDA | 85.35B | 70.41B | 63.56B | 54.25B | 46.30B |
| Net Income | 57.88B | 48.45B | 43.37B | 36.74B | 32.55B |
Balance Sheet | |||||
| Total Assets | 340.78B | 312.98B | 243.48B | 217.37B | 187.37B |
| Cash, Cash Equivalents and Short-Term Investments | 148.64B | 166.78B | 125.19B | 102.12B | 107.26B |
| Total Debt | 5.12B | 11.92B | 12.16B | 11.75B | 6.10B |
| Total Liabilities | 71.90B | 86.68B | 48.40B | 56.24B | 40.89B |
| Stockholders Equity | 268.86B | 226.30B | 195.08B | 161.13B | 146.47B |
Cash Flow | |||||
| Free Cash Flow | 18.86B | 61.34B | 31.79B | 14.37B | 42.88B |
| Operating Cash Flow | 33.27B | 67.62B | 36.92B | 21.79B | 46.95B |
| Investing Cash Flow | -59.23B | -7.27B | -5.96B | -7.68B | -7.43B |
| Financing Cash Flow | -27.64B | -18.73B | -15.97B | -22.48B | -9.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $77.31B | 15.78 | 21.64% | 2.19% | 8.50% | 7.29% | |
69 Neutral | $50.58B | 56.93 | 14.19% | 0.37% | 1.72% | -17.04% | |
67 Neutral | $7.90B | 23.45 | 21.91% | 1.24% | 15.83% | 14.34% | |
63 Neutral | $41.62B | -141.04 | -8.57% | ― | 18.16% | 93.64% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | $33.76B | -30.50 | -276.20% | ― | 38.10% | -16.91% |